Awareness and Impact of Non-pharmaceutical Interventions During Coronavirus Disease 2019 Pandemic in Renal Transplant Recipients

Transplant Proc. 2020 Nov;52(9):2607-2613. doi: 10.1016/j.transproceed.2020.07.010. Epub 2020 Jul 21.

Abstract

The concerns generated by coronavirus disease 2019 (COVID-19) pandemic are having profound impact on solid organ transplantation (SOT). Non-pharmaceutical interventions (NPI) are currently the only measures available to contain COVID-19 in the general population and in more vulnerable recipients of any organ transplant. In this cross-sectional case control study from a patient survey undertaken in 2 transplant centers (TxC) in the Kingdom of Saudi Arabia and Italy, we aimed to appraise awareness of the NPI implemented by respective these governments. We have also evaluated the impact of COVID-19 on our kidney transplant (KT) recipients and a control group of kidney living donors (KLD). In our series, there were zero cases of COVID-19 among 111 KT recipients and 70 KLD of the control group. Demography, transplant type, immunosuppression regimes, and, importantly, the different COVID-19 prevalence in the 2 regions of the TxC did not appear to influence incidence of COVID-19 in our KT recipients. The absence of COVID-19 cases in our series was unexpected. Our findings suggest that awareness of NPI is associated with a successful containment of COVID-19 in vulnerable, immunosuppressed KT recipients.

Publication types

  • Evaluation Study
  • Multicenter Study

MeSH terms

  • Adult
  • Betacoronavirus / immunology*
  • COVID-19
  • Case-Control Studies
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / immunology
  • Cross-Sectional Studies
  • Female
  • Humans
  • Immunocompromised Host / immunology*
  • Incidence
  • Italy / epidemiology
  • Kidney Transplantation / adverse effects*
  • Living Donors / statistics & numerical data
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / immunology
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / immunology
  • Postoperative Complications / virology
  • Prevalence
  • SARS-CoV-2
  • Saudi Arabia / epidemiology
  • Tissue and Organ Harvesting / adverse effects
  • Tissue and Organ Procurement / statistics & numerical data